Cranberry extract vs. low-dose trimethoprim in recurrent UTI
137 older women with two or more antibiotic-treated UTIs in the previous 12 months were randomised to 500 mg cranberry extract or 100 mg trimethoprim for 6 months. 39 participants had an antibiotic-treated UTI (25 cranberry, 14 trimethoprim; relative risk 1.616, 95% CI 0.93–2.79, P = 0.084). Time to first recurrence was not significantly different between groups (84.5 vs 91 days, P = 0.479). The authors concluded trimethoprim had a very limited advantage over cranberry extract and more adverse effects, and that cranberry extract carries no risk of antimicrobial resistance or super-infection.
Trial registration ISRCTN80031108





